A new tandem repeat‐enriched lncRNA XLOC_008672 promotes gastric carcinogenesis by regulating G3BP1 expression

Li Li,Shijun Yu,Ning Dou,Xiao Wang,Yong Gao,Yandong Li

DOI: https://doi.org/10.1111/cas.16172

IF: 5.7

2024-04-07

Cancer Science

Abstract:Our study reveals that FOXM1 transcriptionally activates lncRNA XLOC_008672 expression and this lncRNA can bind to SNRPA to enhance the mRNA stability of G3BP1.The FOXM1/XLOC_008672/SNRPA/G3BP1 signaling axis promotes gastric carcinogenesis. Aberrant expression of forkhead box transcription factor 1 (FOXM1) plays critical roles in a variety of human malignancies and predicts poor prognosis. However, little is known about the crosstalk between FOXM1 and long noncoding RNAs (lncRNAs) in tumorigenesis. The present study identifies a previously uncharacterized lncRNA XLOC_008672 in gastric cancer (GC), which is regulated by FOXM1 and possesses multiple copies of tandem repetitive sequences. LncRNA microarrays are used to screen differentially expressed lncRNAs in FOXM1 knockdown GC cells, and then the highest fold downregulation lncRNA XLOC_008672 is screened out. Sequence analysis reveals that the new lncRNA contains 62 copies of 37‐bp tandem repeats. It is transcriptionally activated by FOXM1 and functions as a downstream effector of FOXM1 in GC cells through in vitro and in vivo functional assays. Elevated expression of XLOC_008672 is found in GC tissues and indicates worse prognosis. Mechanistically, XLOC_008672 can bind to small nuclear ribonucleoprotein polypeptide A (SNRPA), thereby enhancing mRNA stability of Ras‐GTPase‐activating protein SH3 domain‐binding protein 1 (G3BP1) and, consequently, facilitating GC cell proliferation and migration. Our study discovers a new uncharacterized lncRNA XLOC_008672 involved in GC carcinogenesis and progression. Targeting FOXM1/XLOC_008672/SNRPA/G3BP1 signaling axis might be a promising therapeutic strategy for GC.

oncology